Skip to Content

Vanderbilt-Ingram Cancer CenterVanderbilt-Ingram Cancer Center

 

VICC toll-free number 1-877-936-8422

Clinical Trials for Debra Friedman

9 Open Trials

Trial Type Protocol No. &
Open Date
Summary

Basic Science

COGANHL04B1

09/14/2006

Rare and Cutaneous Non-Hodgkin Lymphoma Registry

Health Services Research

VICCNCPED1513

08/28/2015

An Observational, Multi-Center Study to Evaluate the Safety of Deferasirox in the Treatment of Pediatric Patients with Non-Transfusion-Dependent Iron Overload

Health Services Research

VICCREACH1447

04/16/2014

Retinoblastoma Survivor Study (RBSS)

Other

VICREACH1476

09/25/2014

Assessment of Ovarian Reserve in Healthy Adolescents

Other

COGALTE11C1

08/21/2013

ALTE11C1 - Longitudinal Assessment of Ovarian Reserve in Adolescents with Lymphoma

Other

COGALTE03N1

04/20/2005

Key Adverse Events after Childhood Cancer

Supportive Care

VICCREACH1525

05/11/2015

Navigated Early Survivorship Transition (NEST) Project

Treatment

COGAHOD1331

07/15/2015

A Randomized Phase III Study of Brentuximab Vedotin (SGN-35, IND #117117) for Newly Diagnosed High-Risk Classical Hodgkin Lymphoma (cHL) in Children and Adolescents

Treatment

COGAALL1231

05/13/2015

A Phase III Randomized Trial Investigating Bortezomib NSC# 681239; IND# 58443) on a Modified Augmented BFM (ABFM) Backbone in Newly Diagnosed T-Lymphoblastic Leukemia (T-ALL) and T-Lymphoblastic Lymphoma (T-LLy)